New Century Investment Management’s Biogen BIIB Stock Holding History

New Century Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,419	Closed	-$2.19M	–	89
2015 Q2	$2.19M	Hold	5,419	–	–	1.01%	41
2015 Q1	$2.29M	Buy	5,419 +200	+4%	+$78.8K	1.06%	40
2014 Q4	$1.77M	Hold	5,219	–	–	0.88%	43
2014 Q3	$1.73M	Buy	5,219 +200	+4%	+$65.9K	0.89%	47
2014 Q2	$1.58M	Hold	5,019	–	–	0.86%	51
2014 Q1	$1.53M	Buy	5,019 +300	+6%	+$95.2K	0.87%	53
2013 Q4	$1.32M	Hold	4,719	–	–	0.79%	58
2013 Q3	$1.14M	Buy	+4,719	New	+$1.06M	0.77%	59

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

New Century Investment Management's BIIB Position: Q3 2015 in Review

New Century Investment Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 5,419 shares — an estimated $2.19M sold.

New Century Investment Management first reported a position in BIIB in Q3 2013 and held it in 8 quarters. The position peaked at $2.29M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

New Century Investment Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
New Century Investment Management sold 5,419 Biogen shares in Q3 2015, an estimated $2.19M.
New Century Investment Management first reported a position in Biogen in Q3 2013 and held it in 8 quarters.
New Century Investment Management's Biogen position peaked at $2.29M in Q1 2015.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on New Century Investment Management's 13F filing for Q3 2015, filed 19 Oct 2015.